Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : momo-T/FIF -- Ignore unavailable to you. Want to Upgrade?

To: tom pope who wrote (3067)	9/14/2005 2:07:40 PM
From: scaram(o)uche	Respond to of 12215

ask, and you receive.

To: tom pope who wrote (3067)	9/14/2005 3:20:13 PM
From: Icebrg	Read Replies (1) \| Respond to of 12215

>>That MLNM thread is incredibly toxic.>> Yes, it is. I don't read it, really. Just checking what some of the signatures I have found interesting have to say. Boronate seems to have a good handle on things, but secondguessing FDA is of course not so easy. On the other hand, being one of the persons involved in the early development of Velcade - if I have understood things correctly - he might have some positive bias in favour of the drug. Erik